The Clinical Proteomics Platform consists of a dynamic team ready to listen to your questions.
Each member of the laboratory brings his or her own talents and knowledge to make the PPC the best choice for all your projects.
Head of the Clinical Proteomics Platform of Montpellier
Full Professor in Clinical Proteomics and Biochemistry, Christophe Hirtz is specialized in clinical assays and R&D activities in the field of clinical proteomics since 1998 and neurodegenerative diseases since 2010.
Head of the laboratory of Biochemistry and Clinical Proteomics
Prof. Sylvain Lehmann M.D., Ph.D. is professor of Biochemistry at the Medical School of Montpellier. His clinical unit at the University Hospital Center (CHU) is in charge of the biological diagnosis of neurodegenerative disorders and he recently set up a reference Neurological biobank.
MASS SPECTROMETRY Specialist - engineer
ImmunoAssay specialist - engineer
“Hello, I am in charge of immunoassays in the laboratory on the latest technologies, SIMOA and MSD.”
“I perform biological diagnostic assays for neurodegenerative disorders. I also manage samples for our biobank. Furthermore, I’m involved in research projects on new technologies such as SiMoA, MSD and ELLA.”
MASS SPECTROMETRY ENGINEER - SMART PROJECT MANAGER
“Hello everyone, I’m a mass spectrometry engineer and I joined PPC as the SMART project manager. My role is the development and implementation of methods for the detection and quantification of RNA changes.”
Mass spectrometry engineer
“Engineer in mass spectrometry and proteomics, I am in charge of the research project on the TAU protein in multiple neurodegenerative pathologies.”
engineer assistant - plasma boost project manager
“Hello! My name is Jana, I’m 21 years old and I’m from Belgium. I’m responsible for the Plasma Boost project: the detection of amyloid peptides in the blood on a MALDI-TOF (concerning Alzheimer’s disease).”
PhD student from 2019 to 2022
“I’m a PhD student working on the development of innovative method in mass spectrometry for the discovery of biomarkers in the context of neurodegenerative diseases.”
“PhD student working on RNA epigenetic : our goals are to investigate the role of mRNA methylation in colorectal cancer progression and to identify potential RNA modification-based biomarkers in cancer and neurodegenerative diseases using mass spectrometry.”
Biology Engineer - SIMOA Manager
“”Involved in several research projects on neurodegenerative pathologies, I am developing ultrasensitive assays, mainly with the Single Molecule Array (SIMOA)”.”